Year
2025
Summary
This research explores how mast cells—immune cells responsible for allergy symptoms—can be repurposed to strengthen vaccines. By targeting mast cells with nasal vaccines, stronger and longer-lasting immune responses may be generated, particularly benefiting high-risk populations and improving protection against infectious diseases.